Optima Health shares rise 5% on strong earnings and PAM deal progress
Optima Health PLC shares rose 5% following a 10% beat in full-year EBITDA and the resolution of a procurement matter. The company's performance, combined with the PAM Group acquisition, has led to a proforma valuation of 250p per share by Panmure Liberum.
Topics: acquisition analyst upgrade earnings beat procurement settlement stock price movement